SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-026862
Filing Date
2024-06-05
Accepted
2024-06-05 16:31:30
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A blfs-20240605.htm   iXBRL DEF 14A 1063199
3 GRAPHIC blfs-20240605_g1.jpg GRAPHIC 6233
4 GRAPHIC blfs-20240605_g2.jpg GRAPHIC 106270
5 GRAPHIC blfs-20240605_g3.jpg GRAPHIC 121449
6 GRAPHIC blfs-20240605_g4.jpg GRAPHIC 109515
7 GRAPHIC blfs-20240605_g5.jpg GRAPHIC 195193
  Complete submission text file 0001628280-24-026862.txt   2974978

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20240605.xsd EX-101.SCH 940
19 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20240605_htm.xml XML 90762
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

IRS No.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36362 | Film No.: 241022410
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)